Finding an anti-AIDS vaccine remains an elusive goal—partly because the HIV virus quickly mutates to evade the vaccine's antibodies. In a Watson Lecture on April 1, Caltech's Pamela J. Bjorkman will describe ways to neutralize that mutational advantage.
Researchers around the country are adopting a technique developed in the Caltech lab of Nobel Laureate David Baltimore to try to guard against infection. The method, called VIP, was originally designed to trigger an immune response to HIV.
We recently spoke to David Anderson, Caltech's Seymour Benzer Professor of Biology, about this work, his goals, and how the interdisciplinary collaborations he is building at Caltech are helping to spur a revolution in neuroscience.